QUIDELORTHO CORP Increase (Decrease) in Prepaid Expenses, Other
QUIDELORTHO CORP (QDEL) reported Increase (Decrease) in Prepaid Expenses, Other of -$10.30 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-07
- QUIDELORTHO CORP increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-28 was $8.40M, a 27.59% decline year-over-year.
- QUIDELORTHO CORP increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-29 was -$18.70M.
- QUIDELORTHO CORP increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-28 was $18.50M.
- QUIDELORTHO CORP increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-28 was $7.60M, a 35.59% decline year-over-year.
- QUIDELORTHO CORP increase (decrease) in prepaid expenses, other for fiscal 2025 was $34.60M, a 264.21% increase from fiscal 2024.
- QUIDELORTHO CORP increase (decrease) in prepaid expenses, other for fiscal 2024 was $9.50M, a 64.68% decline from fiscal 2023.
- QUIDELORTHO CORP increase (decrease) in prepaid expenses, other for fiscal 2023 was $26.90M, a 2.67% increase from fiscal 2023.
- QUIDELORTHO CORP increase (decrease) in prepaid expenses, other for fiscal 2023 was $26.20M, a 96.99% increase from fiscal 2022.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2026-06-28 | $8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$10.30M 10-Q · filed 2026-08-07 | $8.20M derived: sum of 3 quarters · filed 2026-08-07 | $15.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | -$18.70M 10-Q · filed 2026-05-06 | -$200.00K derived: sum of 2 quarters · filed 2026-05-06 | $7.40M derived: sum of 3 quarters · filed 2026-05-06 | $19.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $26.10M derived: sum of 2 quarters · filed 2026-02-19 | $37.70M derived: sum of 3 quarters · filed 2026-08-07 | $34.60M 10-K · filed 2026-02-19 |
| 2025-09-28 | $7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $19.20M derived: sum of 2 quarters · filed 2026-08-07 | $16.10M 10-Q · filed 2025-11-06 | $2.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $11.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $8.50M 10-Q · filed 2026-08-07 | -$5.50M derived: sum of 3 quarters · filed 2026-08-07 | $6.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | -$3.10M 10-Q · filed 2026-05-06 | -$17.10M derived: sum of 2 quarters · filed 2026-05-06 | -$5.30M derived: sum of 3 quarters · filed 2026-05-06 | $5.60M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | -$14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.20M derived: sum of 2 quarters · filed 2026-02-19 | $8.70M derived: sum of 3 quarters · filed 2026-02-19 | $9.50M 10-K · filed 2026-02-19 |
| 2024-09-29 | $11.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $22.70M derived: sum of 2 quarters · filed 2025-11-06 | $23.50M 10-Q · filed 2025-11-06 | $15.30M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $11.70M 10-Q · filed 2025-08-06 | $3.50M derived: sum of 3 quarters · filed 2026-02-19 | $800.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $800.00K 10-Q · filed 2025-05-08 | -$7.40M derived: sum of 2 quarters · filed 2026-02-19 | -$10.10M derived: sum of 3 quarters · filed 2026-02-19 | -$27.40M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$10.90M derived: sum of 2 quarters · filed 2026-02-19 | -$28.20M derived: sum of 3 quarters · filed 2026-02-19 | $26.90M 10-K · filed 2026-02-19 |
| 2023-10-01 | -$2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$20.00M derived: sum of 2 quarters · filed 2024-11-08 | $35.10M 10-Q · filed 2024-11-08 | $20.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$17.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $37.80M 10-Q · filed 2024-08-01 | $22.70M derived: sum of 3 quarters · filed 2025-02-27 | $54.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $55.10M 10-Q · filed 2024-05-09 | $40.00M derived: sum of 2 quarters · filed 2025-02-27 | $71.50M derived: sum of 3 quarters · filed 2025-02-27 | $74.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | -$15.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $16.40M derived: sum of 2 quarters · filed 2025-02-27 | $18.90M derived: sum of 3 quarters · filed 2025-02-27 | $26.20M 10-K · filed 2025-02-27 |
| 2022-10-02 | $31.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $34.00M derived: sum of 2 quarters · filed 2023-11-02 | $41.30M 10-Q · filed 2023-11-02 | $39.40M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $9.80M 10-Q · filed 2023-08-09 | $7.90M derived: sum of 3 quarters · filed 2024-08-01 | $2.00M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $7.30M 10-Q · filed 2023-05-04 | $5.40M derived: sum of 2 quarters · filed 2024-08-01 | -$500.00K derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | -$1.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | -$7.80M derived: sum of 2 quarters · filed 2024-08-01 | $13.30M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | -$5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $15.20M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $21.10M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $14.30M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |